(Q34355792)

English

Use of imputed population-based cancer registry data as a method of accounting for missing information: application to estrogen receptor status for breast cancer

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Use of imputed population-based cancer registry data as a method of accounting for missing information: application to estrogen receptor status for breast cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Kathleen A. Cronin

4

object named as

Kathleen A Cronin

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

author name string

Nadia Howlader

1

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Anne-Michelle Noone

2

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Mandi Yu

3

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

language of work or name

0 references

publication date

25 July 2012

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

American Journal of Epidemiology

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

176

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

347-356

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Incidence of breast cancer in the United States: current and future trends.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3491971

6 July 2018

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3491971

6 July 2018

Feasibility study for collection of HER2 data by National Cancer Institute (NCI) Surveillance, Epidemiology, and End Results (SEER) Program central cancer registries

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3491971

6 July 2018

Race/ethnicity and breast cancer estrogen receptor status: impact of class, missing data, and modeling assumptions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3491971

6 July 2018

American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3491971

6 July 2018

Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3491971

6 July 2018

Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3491971

6 July 2018

The decrease in breast-cancer incidence in 2003 in the United States

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3491971

6 July 2018

Much ado about nothing: A comparison of missing data methods and software to fit incomplete data regression models

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3491971

6 July 2018

Geocoding and monitoring of US socioeconomic inequalities in mortality and cancer incidence: does the choice of area-based measure and geographic level matter?: the Public Health Disparities Geocoding Project

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3491971

6 July 2018

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3491971

6 July 2018

Racial differences in breast cancer trends in the United States (2000-2004).

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWR512

21 January 2018

Breast cancer incidence rates in U.S. women are no longer declining

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWR512

21 January 2018

Sustained lower rates of breast cancer in the United States

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWR512

21 January 2018

Permutation tests for joinpoint regression with applications to cancer rates

1 reference

https://pubmed.ncbi.nlm.nih.gov/22842721

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1093/AJE/KWR512

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34355792&oldid=2136690835"